Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Mal Respir ; 39(10): 848-854, 2022 Dec.
Artigo em Francês | MEDLINE | ID: mdl-36336524

RESUMO

INTRODUCTION: Pediatric cancers are a major public health problem in sub-Saharan Africa. However, they are seldom studied, especially as regards in their extensive forms. METHODOLOGY: An eight-year retrospective and descriptive study was carried out so as to specify the epidemiological and clinical characteristics of cancers with pleural and pulmonary involvement in children of 0 to 14years of age in the pediatric oncology unit at the University Hospital of Treichville, Côte d'Ivoire (Ivory Coast). RESULTS: The frequency of pleural and pulmonary involvement in pediatric cancers was 13.8%. Children's average age was 7.2years, with sex ratio at 2.11. Solid tumors were predominant, with a predominance of Burkitt's lymphoma (39.3%) and nephroblastoma (35.7%). The most affected age groups were 10 to 15years (Burkitt's lymphoma) and 0 to 5years (nephroblastoma). Time to diagnosis ranged from 31 and 60days in 40.4% of cases, and time to treatment was at most 30 days, for the overwhelming majority (97.1%) of the children. Chemotherapy was initiated in 67.9% of patients. Hospital mortality was 73.2%. CONCLUSION: Through this study, the authors established the profile of childhood cancers with pleural and pulmonary involvement. Comparative studies of mortality in pediatric cancers with and without pleural and pulmonary involvement could further underline the importance of early management before dissemination.


Assuntos
Linfoma de Burkitt , Tumor de Wilms , Criança , Humanos , Adolescente , Côte d'Ivoire/epidemiologia , Estudos Retrospectivos , Linfoma de Burkitt/epidemiologia , Linfoma de Burkitt/terapia , Hospitais Universitários , Tumor de Wilms/epidemiologia , Tumor de Wilms/terapia
2.
Rev Pneumol Clin ; 72(6): 340-345, 2016 Dec.
Artigo em Francês | MEDLINE | ID: mdl-27776945

RESUMO

INTRODUCTION: The National tuberculosis program (NTP) in Ivory Coast recommends that children under 5 years living in a family environment with contagious tuberculosis patients, should receive Prophylactic treatment with INH (PTI), whatever the result of the tuberculin skin test (positive or negative) and their BCG status (vaccinated or not), at a dose of 5mg/kg/day for 6 months. We conducted this study to check the implementation of this recommendation in three support services of tuberculosis in Abidjan, the economic capital. MATERIAL AND METHOD: We conducted a multicenter, cross-sectional and descriptive study over 3 years (2011-2013), on consented patients, adolescents and adults aged at least 15 years, with a first episode of infectious pulmonary tuberculosis, in order to look for information on the INH prophylaxis in children under 5 years living under the same roof. We made patients interviews during their visit for bacteriological sputum controls at the second month of TB treatment. RESULTS: Of a total of 412 patients (53% males and 47% females) with a mean age of 34.5 years and with a low level of instruction (66.5%), we noticed 639 children under 5 years living under the same roof with them. Information on the screening of contact children was given to 71% of interviewed patients (291/412). Of the 339 children examined among 639 contacts, 234 (69%) had received only an intradermoreaction (IDR) and PTI was finally administered to 64% of them (217/339). CONCLUSION: High proportion of contact children under 5 not examined is a major concern for the NTP and a missed opportunity to prevent additional cases of tuberculosis among children.


Assuntos
Isoniazida/uso terapêutico , Prevenção Primária/estatística & dados numéricos , Tuberculose Pulmonar/prevenção & controle , Adolescente , Adulto , Quimioprevenção/métodos , Quimioprevenção/estatística & dados numéricos , Criança , Pré-Escolar , Busca de Comunicante/estatística & dados numéricos , Côte d'Ivoire/epidemiologia , Estudos Transversais , Feminino , Humanos , Lactente , Masculino , Mycobacterium tuberculosis , Prevenção Primária/métodos , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/microbiologia , Adulto Jovem
3.
Rev Mal Respir ; 32(5): 513-8, 2015 May.
Artigo em Francês | MEDLINE | ID: mdl-26072008

RESUMO

INTRODUCTION: Smoking promotes, among other health problems, the development of tuberculosis and the discovery of a case of tuberculosis can therefore be an opportunity for tobacco control interventions. METHODS: We conducted a prospective study evaluating the knowledge of 37 Ivorian physicians (32 men and 5 women with 5 active smokers) on the relationship between smoking and tuberculosis and their attitudes to smoking tuberculous patients between February and August 2012 using an anonymous self-administered questionnaire. RESULTS: The response rate to the questionnaire was 88.1%. Among them, 70.3% of Ivorian physicians knew that smoking increased the incidence of tuberculosis, 75.7% said that forms of tuberculosis were more severe in smokers and about 27% thought that the cure rate of tuberculosis was lower in smokers. No significant difference was observed according to respondents' smoking status, or gender. Patients' smoking status was always assessed by 64.9% of physicians and by 78.4% in patients with tuberculosis, again not differing by physicians' smoking status or gender. The risks of smoking were always explained to patients with active pulmonary tuberculosis by 43.2% and benefits of stopping smoking ware always described in 35.1%. An intervention for smoking cessation was systematically offered to smokers having tuberculosis by 59.4% of physicians and 8.1% offered medication for smoking cessation. CONCLUSION: These results strongly support the need to reinforce physician behaviors to address smoking in patients with tuberculosis in Ivory Coast.


Assuntos
Atitude do Pessoal de Saúde , Conhecimentos, Atitudes e Prática em Saúde , Médicos/psicologia , Padrões de Prática Médica/estatística & dados numéricos , Abandono do Hábito de Fumar/psicologia , Fumar/psicologia , Tuberculose/psicologia , Adulto , Côte d'Ivoire , Suscetibilidade a Doenças , Feminino , Hospitais de Doenças Crônicas , Hospitais Universitários , Humanos , Incidência , Masculino , Corpo Clínico Hospitalar/psicologia , Pessoa de Meia-Idade , Papel do Médico , Estudos Prospectivos , Pneumologia , Fumar/efeitos adversos , Inquéritos e Questionários , Tuberculose/etiologia
4.
Rev Pneumol Clin ; 69(5): 237-43, 2013 Oct.
Artigo em Francês | MEDLINE | ID: mdl-23707224

RESUMO

OBJECTIVES: To specify consequences of armed conflict in Côte d'Ivoire from 2002 to 2007 on treatment outcomes of new cases of smear-positive pulmonary tuberculosis (PTB+) and retreatment cases. METHODOLOGY: Retrospective analysis of treatment outcomes and reprocessing notified to the National Program against Tuberculosis from 2001 to 2008. RESULTS: Totally, 7,4232 cases of TPM+ and 5094 cases of reprocessing had been declared during the war period in Côte d'Ivoire. The global average rate of therapeutic success was 72% with a lower average rate of success in retreatment in Center, Northern et Western (CNO) zone (54%) than in Southern zone (73%). The average rate of lost sight was higher in CNO zone than in the South with respectively 27% and 11%. The average rate of success in retreatment was 60% on the national level with a lower rate in CNO zone (48%) than in the South zone (62%) and the average rate of lost sight in retreatment was higher in CNO zone than in the South zone (28% versus 16%). CONCLUSION: Our results show that there was no early epidemic of tuberculosis during the armed conflict in Côte d'Ivoire which has although severely disrupted activities of tuberculosis management in ex-nongovernmental zone.


Assuntos
Controle de Doenças Transmissíveis , Tuberculose Pulmonar/epidemiologia , Tuberculose Pulmonar/prevenção & controle , Guerra , Controle de Doenças Transmissíveis/normas , Controle de Doenças Transmissíveis/estatística & dados numéricos , Côte d'Ivoire/epidemiologia , Geografia , Humanos , Programas de Rastreamento , Recidiva , Retratamento , Estudos Retrospectivos , Resultado do Tratamento , Tuberculose Pulmonar/terapia , Tuberculose Pulmonar/transmissão
5.
Rev Pneumol Clin ; 68(1): 50-3, 2012 Feb.
Artigo em Francês | MEDLINE | ID: mdl-22305138

RESUMO

Chylothorax is a rare disorder occurring most often in aftermath of a thoracic surgery or during cancer of mediastinum. We report the clinical history of the world's second case of chylothorax which appeared during treatment with simvastatin.


Assuntos
Quilotórax/etiologia , Mediastino/patologia , Sinvastatina/efeitos adversos , Ducto Torácico/patologia , Idoso de 80 Anos ou mais , Quilotórax/diagnóstico , Humanos , Masculino , Mediastino/diagnóstico por imagem , Radiografia , Ducto Torácico/diagnóstico por imagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA